Un abonnement à JoVE est nécessaire pour voir ce contenu. Connectez-vous ou commencez votre essai gratuit.
Chapitres
- 00:05Introduction
- 00:19What is Parkinson’s disease?
- 01:44Currently available therapies
- 04:14Current strategies towards the development of new therapies
- 07:29Isacson lab: finding genetic determinants of Parkinson’s disease
- 09:37Why is translation of scientific findings to new therapies so slow?
- 14:13Academic research and translational medicine: friends or foes?
- 16:20Perspective on future research directions
- 18:31Genetic and idiopathic diseases: Parkinson’s and Huntington’s
- 20:07What would you do if you were starting your post-doc now?
- 23:23References
Tags
Ole IsacsonA Renowned ScientistIs Dedicated To The Development Of New Therapies For Parkinson’s Disease. His Groundbreaking Research Focuses On Finding Innovative Treatments That Can Slow Down Or Even Halt The Progression Of This Debilitating Neurodegenerative Disorder.Isacson’s Work Involves Understanding The Underlying Mechanisms Of Parkinson’s Disease And Identifying Potential Targets For Therapeutic Interventions. By Studying The Pathology Of The Disease And Its Impact On Brain CellsHe Aims To Discover Novel Approaches To Prevent The Loss Of Dopamine-producing NeuronsWhich Is A Hallmark Of Parkinson’s.One Of Isacson’s Notable Contributions Is In The Field Of Stem Cell Therapy. He Has Been At The Forefront Of Utilizing Induced Pluripotent Stem Cells (iPSCs) To Generate Dopamine-producing Neurons In The Laboratory. This Breakthrough Technique Holds Immense Promise For Developing Patient-specific Cell Replacement TherapiesProviding A Potential Cure For Parkinson’s.In A
